Daily FNArena News

A study by Danske Bank concludes the euro will be among the beneficiaries of slowing economic growth.

Agrichemicals group Nufarm remains an attractive corporate target, brokers say. They expect investors to focus on earnings again post the failed approach by ChemChina.

NAB has released the results of its November business survey.

The Dow rallied 100 points last night despite another big subprime write-down – this time from UBS.

The rumour is US private equity firm Blackstone is now in the race for Rio Tinto.

ANZ Bank’s latest survey into job ads in Australia revealed a new record for November, but ANZ economists believe employment growth is nevertheless likely to slow down from here.

Intrinsic valuation for biotech Chemgenex might receive a boost soon as ABN Amro Morgans analysts are reviewing their model post some better than expected clinical results.

SP Ausnet is not pursuing the purchase of Alinta assets, no doubt to great delight of most minority shareholders. But what now?

Fed rate decision.

At 94,000, US jobs growth found an equilibrium point that resulted in a flat close on Wall Street.